{
  "ticker": "RHY",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972194",
  "id": "02972194",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250724",
  "time": "0907",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m2zhklc1c86d.pdf",
  "summary": "### Summary of ASX Announcement:  \n**Type: Strategic Collaboration Announcement**  \n\n- **Key Agreement**: Service agreement with Memorial Sloan Kettering Cancer Center (MSK) to support clinical trials on **Breast and Prostate Cancer Risk** using geneType\u2122.  \n- **Scope**: Minimum **300 participants** across two studies, building on prior BRCA1/2-related research.  \n- **Partners**: Collaboration with MSK\u2019s Drs. Ken Offit, Jada Hamilton, and Mark Robson (renowned in polygenic risk score research).  \n\n**Material Impact**:  \n- Strengthens **commercial validity** of geneType\u2122 through collaboration with a top-tier cancer research institution.  \n- Potential **future revenue stream** from clinical trial services (no financial terms disclosed).  \n\nOmitted: Background on directors, general company overview, non-material operational details.",
  "usage": {
    "prompt_tokens": 1341,
    "completion_tokens": 180,
    "total_tokens": 1521,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-23T23:16:21.227985"
}